EN
HI
Summary
As of 10 Nov, 2026, Emmessar Biotech & Nutrition stock price is ₹23.98. During the trading session, the stock has moved between an intraday low of ₹22.89 and an intraday high of ₹25.70. Over the last 52 weeks, Emmessar Biotech & Nutrition has traded between ₹18.42 and ₹33.38.
The stock has recorded a trading volume of 37,047 shares,. Its Average Traded Price (ATP) is ₹24.51, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹23.98.
Emmessar Biotech & Nutrition has an upper circuit limit of ₹25.70 and a lower circuit limit of ₹17.14. The total value traded stands at ₹9.08 L, and the delivery percentage for the day is 88.91%.
The stock is currently traded with a market lot size of 1. Emmessar Biotech & Nutrition also offers a dividend yield of 0%.
Emmessar Biotech & Nutrition Share Price Chart
Emmessar Biotech & Nutrition Share Key Metrics
Volume
37047.00
Market Cap
11.98 CR
LTQ@LTP
1@23.98
ATP
24.51
Var Margin
29.75 %
Circuit Range
17.14-25.7
Delivery %
88.91 %
Value
9.08 L
ASM/GSM
No
Market Lot
1
Emmessar Biotech & Nutrition Resistance and Support
Pivot 21.94
Resistance
First Resistance
22.82
Second Resistance
24.22
Third Resistance
25.1
Support
First Support
20.54
Second Support
19.66
Third Support
18.26
Emmessar Biotech & Nutrition Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Nov 09 2026 | 22.9 | 23.98 | 11.95% | 25.7 | 22.89 |
| Sun Nov 08 2026 | 23.34 | 21.42 | -4.72% | 23.34 | 21.05 |
| Fri Nov 06 2026 | 22.48 | 22.48 | -0.09% | 22.48 | 22.04 |
Emmessar Biotech & Nutrition Corporate Actions
| Date | Agenda |
|---|---|
| 2026-10-31 | Quarterly Results |
| 2026-08-07 | Quarterly Results |
| 2026-05-12 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-07 | Quarterly Results |
| 2025-04-24 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-07 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Emmessar Biotech & Nutrition News
Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Outcome for For Unaudited Financial Results For Period Ending 30/09/2026
Emmessar Biotech reported Q2 FY27 revenue of ₹10.92 lakhs and a net profit of ₹14.03 lakhs, marking a 23% YoY growth in profit. The statutory auditors V Nagarajan & Co have issued an unmodified limited review report for the quarter.
Oct 31 2026 15:55:22
Emmessar Biotech & Nutrition Ltd - 524768 - Board Meeting Intimation for Unaudited Results For The Quarter Ended September 30, 2026
Emmessar Biotech board to meet on 31 Oct 2026 for financial results.
Oct 23 2026 17:10:39
Emmessar Biotech & Nutrition Management
| Name | Position |
|---|---|
| Priyanka Sharma | Company Secretary & Compliance Officer |
| Srinivasa Raghavan Mathurakavi Ayyangar | Managing Director |
Emmessar Biotech & Nutrition Similar Stocks
Gujarat Inject (Kerala) Ltd.
10.87
0.18 (1.68%)
Tejnaksh Healthcare Ltd.
13.00
0.47 (3.75%)
Ishita Drugs & Industries Ltd.
74.90
2.79 (3.87%)
Venmax Drugs And Pharmaceuticals Ltd.
14.65
0.39 (2.73%)
Beryl Drugs Ltd.
25.49
-0.21 (0.82%)
Sharma East India Hospitals & Medical Research Ltd
81.76
-3.24 (3.81%)
Norris Medicines Ltd.
14.25
-0.75 (5.00%)
Emmessar Biotech & Nutrition FAQs
The Buying Price of Emmessar Biotech & Nutrition share is 23.98 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Emmessar Biotech & Nutrition stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Emmessar Biotech & Nutrition, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Emmessar Biotech & Nutrition shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Emmessar Biotech & Nutrition shares is 0. Useful to assess the stock's value relative to its book value.
To assess Emmessar Biotech & Nutrition’s valuation compare Sector P/E, P/B which are 40.79 & 3.79 with sector averages, along with growth rates and financial metrics.
The Market Cap of Emmessar Biotech & Nutrition is 11.98 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Emmessar Biotech & Nutrition share price is 33.38 & 18.42. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Emmessar Biotech & Nutrition belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in EMMESSA
